Bank OZK’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$496K Sell
8,173
-203
-2% -$11.8K 0.17% 103
2025
Q4
$452K Sell
8,376
-96
-1% -$4.62K 0.16% 111
2025
Q3
$382K Buy
8,472
+811
+11% +$37.9K 0.14% 112
2025
Q2
$355K Sell
7,661
-159
-2% -$7.8K 0.14% 113
2025
Q1
$477K Sell
7,820
-717
-8% -$41.8K 0.2% 98
2024
Q4
$483K Sell
8,537
-1,036
-11% -$57.9K 0.2% 97
2024
Q3
$495K Sell
9,573
-1,456
-13% -$68.3K 0.2% 98
2024
Q2
$458K Sell
11,029
-2,129
-16% -$95.3K 0.2% 99
2024
Q1
$714K Sell
13,158
-1,352
-9% -$68.9K 0.32% 91
2023
Q4
$745K Sell
14,510
-1,686
-10% -$88.5K 0.36% 84
2023
Q3
$940K Sell
16,196
-7,960
-33% -$488K 0.52% 72
2023
Q2
$1.54M Sell
24,156
-7,158
-23% -$480K 0.74% 43
2023
Q1
$2.17M Sell
31,314
-1,282
-4% -$90.4K 1.08% 31
2022
Q4
$2.35M Sell
32,596
-1,832
-5% -$138K 1.16% 30
2022
Q3
$2.45M Sell
34,428
-20,388
-37% -$1.48M 1.33% 24
2022
Q2
$4.22M Sell
54,816
-515
-0.9% -$39.2K 2.14% 9
2022
Q1
$4.04M Sell
55,331
-83
-0.1% -$5.57K 1.73% 15
2021
Q4
$3.46M Sell
55,414
-361
-0.6% -$21.2K 1.41% 22
2021
Q3
$3.3M Sell
55,775
-2,804
-5% -$185K 1.49% 19
2021
Q2
$3.91M Buy
58,579
+649
+1% +$42.3K 1.73% 13
2021
Q1
$3.66M Buy
57,930
+277
+0.5% +$17.2K 1.68% 16
2020
Q4
$3.58M Buy
57,653
+1,533
+3% +$94.3K 1.76% 14
2020
Q3
$3.38M Buy
56,120
+3,360
+6% +$202K 1.81% 12
2020
Q2
$3.1M Buy
52,760
+560
+1% +$33.5K 1.76% 13
2020
Q1
$2.91M Sell
52,200
-1,925
-4% -$118K 1.6% 12
2019
Q4
$3.47M Buy
54,125
+1,367
+3% +$78.3K 1.37% 17
2019
Q3
$2.68M Sell
52,758
-1,024
-2% -$48.1K 1.18% 22
2019
Q2
$2.44M Sell
53,782
-772
-1% -$36K 1.06% 22
2019
Q1
$2.6M Sell
54,554
-2,050
-4% -$102K 1.13% 20
2018
Q4
$2.94M Sell
56,604
-836
-1% -$44.9K 1.48% 16
2018
Q3
$3.57M Buy
57,440
+1,447
+3% +$85.9K 1.42% 11
2018
Q2
$3.1M Sell
55,993
-165
-0.3% -$8.91K 1.22% 15
2018
Q1
$3.55M Sell
56,158
-5,971
-10% -$384K 1.41% 8
2017
Q4
$3.81M Buy
62,129
+230
+0.4% +$14.4K 1.44% 9
2017
Q3
$3.94M Sell
61,899
-1,045
-2% -$61K 1.63% 6
2017
Q2
$3.51M Sell
62,944
-1,919
-3% -$104K 1.25% 10
2017
Q1
$3.53M Buy
64,863
+3,187
+5% +$175K 1.14% 11
2016
Q4
$3.6M Buy
61,676
+3,645
+6% +$199K 1.17% 10
2016
Q3
$3.13M Buy
58,031
+335
+0.6% +$21.5K 1.13% 14
2016
Q2
$4.24M Buy
57,696
+4,981
+9% +$352K 1.54% 7
2016
Q1
$3.37M Buy
52,715
+2,795
+6% +$176K 1.23% 10
2015
Q4
$3.43M Sell
49,920
-2,404
-5% -$159K 1.2% 8
2015
Q3
$3.1M Sell
52,324
-176
-0.3% -$11.2K 1.18% 9
2015
Q2
$3.49M Buy
52,500
+260
+0.5% +$17.1K 1.21% 7
2015
Q1
$3.37M Buy
52,240
+2,280
+5% +$143K 1.21% 7
2014
Q4
$2.95M Buy
49,960
+3,413
+7% +$192K 1.02% 10
2014
Q3
$2.38M Buy
46,547
+2,758
+6% +$138K 0.89% 12
2014
Q2
$2.12M Buy
43,789
+3,010
+7% +$148K 0.74% 16
2014
Q1
$2.12M Buy
40,779
+3,072
+8% +$163K 0.76% 13
2013
Q4
$2M Buy
37,707
+1,520
+4% +$77.4K 0.77% 15
2013
Q3
$1.68M Buy
36,187
+14,081
+64% +$618K 0.73% 17
2013
Q2
$988K Buy
+22,106
New +$960K 0.73% 16

Other funds holding BMY

Bank OZK's BMY Position: Q1 2026 in Review

Bank OZK reduced its Bristol-Myers Squibb (BMY) stake by 2.4% in Q1 2026, selling an estimated $11.8K and leaving 8,173 shares worth $496K. The position accounts for 0.17% of the portfolio, ranked #103.

Bank OZK first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.24M in Q2 2016. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Bank OZK held 8,173 shares of Bristol-Myers Squibb worth $496K as of Q1 2026.
  • Bank OZK sold 203 Bristol-Myers Squibb shares in Q1 2026, an estimated $11.8K.
  • Bristol-Myers Squibb made up 0.17% of Bank OZK's portfolio in Q1 2026, its #103 holding.
  • Bank OZK first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Bank OZK's Bristol-Myers Squibb position peaked at $4.24M in Q2 2016.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Bank OZK's 13F filing for Q1 2026, filed 13 May 2026.